Jump to content

User:Avocado J/Avocado Pharma

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Avocado J (talk | contribs) at 13:49, 1 September 2020 (Created page with '{{short description|US pharmaceutical company}} {{Infobox company | name = Avocado Pharma | logo = | logo_caption = | image = | image_caption = | type = P...'). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)
Avocado Pharma
Company typePublic
IndustryBiopharmaceutical
Pharmaceutical industry
Founded2030; 6 years' time (2030)
FounderM. M. Gunathilake
HeadquartersMiami, Florida, Florida, United States
Area served
Worldwide
(180+ countries)
Key people
M. M. Gunathilake
(President)
A. D. Gunathilake
(CEO)
C. B. Nugarae
(Chairman)
ProductsSee list of Avocado Pharma products
RevenueIncrease US$110.059 billion (2032)
Increase US$82.059 billion (2032)
Increase US$58.88 billion (2032)
Total assetsIncrease US$198.321 billion (2032)
Total equityIncrease US$92.102 billion (2032)
Number of employees
Increase 132,023 (2032)
ParentNugara Inc,.
Websiteavocado.com

Avocado Pharma is an American publicly traded biopharmaceutical company founded in 2025. It originated as a spin-off of MMG Laboratories.